標(biāo)題: Titlebook: Advantages and Problems with Non-Opioids in Pain Management; Vancouver, Canada, A Michael J. Parnham Conference proceedings 1997 Birkh?user [打印本頁] 作者: 去是公開 時(shí)間: 2025-3-21 18:48
書目名稱Advantages and Problems with Non-Opioids in Pain Management影響因子(影響力)
書目名稱Advantages and Problems with Non-Opioids in Pain Management影響因子(影響力)學(xué)科排名
書目名稱Advantages and Problems with Non-Opioids in Pain Management網(wǎng)絡(luò)公開度
書目名稱Advantages and Problems with Non-Opioids in Pain Management網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Advantages and Problems with Non-Opioids in Pain Management被引頻次
書目名稱Advantages and Problems with Non-Opioids in Pain Management被引頻次學(xué)科排名
書目名稱Advantages and Problems with Non-Opioids in Pain Management年度引用
書目名稱Advantages and Problems with Non-Opioids in Pain Management年度引用學(xué)科排名
書目名稱Advantages and Problems with Non-Opioids in Pain Management讀者反饋
書目名稱Advantages and Problems with Non-Opioids in Pain Management讀者反饋學(xué)科排名
作者: Repatriate 時(shí)間: 2025-3-21 22:23
https://doi.org/10.1007/978-981-99-1098-4in children, who have increased susceptibility to several adverse effects of NSAIDs. Recent clinical and epidemiological studies confirm the experience of many clinicians that dipyrone is more potent than paracetamol, safer than NSAIDs and an effective analgesic for the treatment of both acute and chronic pain.作者: 神刊 時(shí)間: 2025-3-22 01:55
Dipyrone in pain management,cyclo-oxygenase inhibitor, its use is not associated with gastric irritation, an important advantage for long-term administration. Uniquely, dipyrone has intrinsic spasmolytic activity. This makes the drug particularly useful in renal colic pain.作者: 不整齊 時(shí)間: 2025-3-22 08:00
Concluding remarks,in children, who have increased susceptibility to several adverse effects of NSAIDs. Recent clinical and epidemiological studies confirm the experience of many clinicians that dipyrone is more potent than paracetamol, safer than NSAIDs and an effective analgesic for the treatment of both acute and chronic pain.作者: 從容 時(shí)間: 2025-3-22 09:35 作者: watertight, 時(shí)間: 2025-3-22 14:32
Advantages and Problems with Non-Opioids in Pain Management978-3-0348-8865-3作者: POLYP 時(shí)間: 2025-3-22 18:54 作者: CAB 時(shí)間: 2025-3-22 21:17
Comparative safety of non-opioids,astic anemia, anaphylaxis and gastrointestinal (GI) bleeding. Ten publications on a total of 11 studies were selected, which provided data on the overall incidence rate of AEs with non-opioid analgesics, case fatality rates and relative risks.作者: Abominate 時(shí)間: 2025-3-23 03:50
https://doi.org/10.1007/978-981-99-1098-4Effective though they are in the treatment of a wide variety of painful conditions, opioids are not always the most suitable analgesic therapy. Tried and tested non-opioid analgesics are frequently preferable, especially for the treatment of mild to moderate pain, because of their lower incidence of side-effects or more relevant sites of action.作者: 萬花筒 時(shí)間: 2025-3-23 06:31 作者: 天文臺(tái) 時(shí)間: 2025-3-23 13:18 作者: insipid 時(shí)間: 2025-3-23 15:08
Introduction,Effective though they are in the treatment of a wide variety of painful conditions, opioids are not always the most suitable analgesic therapy. Tried and tested non-opioid analgesics are frequently preferable, especially for the treatment of mild to moderate pain, because of their lower incidence of side-effects or more relevant sites of action.作者: Projection 時(shí)間: 2025-3-23 20:14 作者: 不易燃 時(shí)間: 2025-3-24 00:59
Non-opioids in cancer pain management,With all the elegant delivery forms now available for opioids in the treatment of cancer pain, it may seem to some that non-opioids have little place in the management of pain for this indication. This impression requires correction.作者: 新手 時(shí)間: 2025-3-24 02:35 作者: 溫和女人 時(shí)間: 2025-3-24 06:51 作者: Irrigate 時(shí)間: 2025-3-24 11:38
http://image.papertrans.cn/a/image/150389.jpg作者: Dedication 時(shí)間: 2025-3-24 15:02
Overview: 978-3-7643-5678-1978-3-0348-8865-3作者: 設(shè)施 時(shí)間: 2025-3-24 22:34
https://doi.org/10.1007/978-981-99-1098-4c efficacy of dipyrone is broad and comparable to that of the non-steroidal anti-inflammatory drugs (NSAIDs) and tramadol. Because dipyrone is a weak cyclo-oxygenase inhibitor, its use is not associated with gastric irritation, an important advantage for long-term administration. Uniquely, dipyrone 作者: inclusive 時(shí)間: 2025-3-25 01:20
https://doi.org/10.1007/978-981-99-1098-4rofile and incidence of other AEs are not taken into account. An approach to the evaluation of the public health impact of AEs with non-opioid analgesics has now been taken in which the total risk of short-term use of these drugs in the community was estimated. The three dimensional approach involve作者: 陰謀小團(tuán)體 時(shí)間: 2025-3-25 05:30 作者: Archipelago 時(shí)間: 2025-3-25 09:14
Dipyrone in pain management,c efficacy of dipyrone is broad and comparable to that of the non-steroidal anti-inflammatory drugs (NSAIDs) and tramadol. Because dipyrone is a weak cyclo-oxygenase inhibitor, its use is not associated with gastric irritation, an important advantage for long-term administration. Uniquely, dipyrone 作者: Aggressive 時(shí)間: 2025-3-25 11:48
Comparative safety of non-opioids,rofile and incidence of other AEs are not taken into account. An approach to the evaluation of the public health impact of AEs with non-opioid analgesics has now been taken in which the total risk of short-term use of these drugs in the community was estimated. The three dimensional approach involve作者: 無動(dòng)于衷 時(shí)間: 2025-3-25 16:11
Concluding remarks,several clinicians from Europe, Latin-America and Asia with long experience with dipyrone use in clinical practice emphasized its value, particularly in children, who have increased susceptibility to several adverse effects of NSAIDs. Recent clinical and epidemiological studies confirm the experienc作者: Opponent 時(shí)間: 2025-3-25 21:28
7樓作者: BOOM 時(shí)間: 2025-3-26 01:41
7樓作者: squander 時(shí)間: 2025-3-26 07:42
7樓作者: CREST 時(shí)間: 2025-3-26 08:30
8樓作者: aviator 時(shí)間: 2025-3-26 13:29
8樓作者: Retrieval 時(shí)間: 2025-3-26 17:35
8樓作者: entail 時(shí)間: 2025-3-26 21:27
8樓作者: 群居男女 時(shí)間: 2025-3-27 02:11
9樓作者: 別名 時(shí)間: 2025-3-27 08:36
9樓作者: kidney 時(shí)間: 2025-3-27 09:56
9樓作者: 法律的瑕疵 時(shí)間: 2025-3-27 16:56
10樓作者: 證明無罪 時(shí)間: 2025-3-27 18:12
10樓作者: 繞著哥哥問 時(shí)間: 2025-3-27 22:17
10樓作者: eczema 時(shí)間: 2025-3-28 04:00
10樓
